Statement: the primary clinical trial and the secondary clinical trial both provide a comprehensive report of all adverse events
Primary_evidence: Adverse Events 1:   Total: 0/23 (0.00%)
Secondary_evidence: Adverse Events 1:   Total: 0/655 (0.00%) Adverse Events 2:   Total: 0/580 (0.00%)